The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial study of bendamustine, ofatumumab, and pentostatin (BOP) as salvage regimen for patients with relapsed or refractory non-Hodgkin’s lymphoma or chronic lymphocytic leukemia.
 
Colin Thomas
Employment - eleison pharmaceuticals (I)
Stock and Other Ownership Interests - eleison pharmaceuticals (I)
 
Sameh Gaballa
No Relationships to Disclose
 
Martina DiMeglio
No Relationships to Disclose
 
Seyfettin Onder Alpdogan
No Relationships to Disclose
 
Matthew H. Carabasi
No Relationships to Disclose
 
Andrew E. Chapman
No Relationships to Disclose
 
Neal Flomenberg
No Relationships to Disclose
 
John L. Wagner
No Relationships to Disclose
 
Joanne Filicko
No Relationships to Disclose
 
Mark Adam Weiss
No Relationships to Disclose